Side effects of mTOR-inhibiting therapies include severe infections as well as aplasia syndromes like anemia and thrombopenia (137) and metabolic side effects such as hyperlipidemia and hyperglycemia (138). The gene discussed is MTOR; the disease is Hyperglycemia.